Showing results (111-120 of 169) with videos related to
Sort By:
Pageof 17
Oncoimmunology|March 26, 2019
The density of Tbet+ tumor-infiltrating T lymphocytes reflects an effective and druggable preexisting adaptive antitumor immune response in colorectal cancer, irrespective of the microsatellite statusEva Ott, Linda Bilonda, Delphine Dansette, et al.Future Oncology (London, England)|April 2, 2020
Quality of life with second or third line <i>nab</i>-paclitaxel-based regimens in advanced non-small-cell lung cancerSantiago Ponce Aix, Denis Talbot, Ramaswamy Govindan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2022
Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer Harboring <i>HER2</i> Mutations: Results From the IFCT-1703 R2D2 TrialJulien Mazieres, Claire Lafitte, Charles Ricordel, et al.European Journal of Cancer (Oxford, England : 1990)|April 30, 2017
Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effectsSimon Pernot, Cecile Badoual, Magali Terme, et al.European Journal of Cancer (Oxford, England : 1990)|September 22, 2014
Gemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: Fédération Francophone de Cancérologie Digestive 9902 phase II randomised studyJean-Marc Phelip, Véronique Vendrely, Florian Rostain, et al.Biology|April 30, 2021
The Expression of Anti-Müllerian Hormone Type II Receptor (AMHRII) in Non-Gynecological Solid Tumors Offers Potential for Broad Therapeutic Intervention in CancerJean-Marc Barret, André Nicolas, Anne Jarry, et al.The Lancet. Oncology|November 22, 2012
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trialJaafar Bennouna, Javier Sastre, Dirk Arnold, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Phase III trial comparing vinflunine with docetaxel in second-line advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapyMaciej Krzakowski, Rodryg Ramlau, Jacek Jassem, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2018
Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9)Thomas Aparicio, Francois Ghiringhelli, Valérie Boige, et al.Journal of the National Cancer Institute|April 20, 2017
Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer PatientsFabrice Denis, Claire Lethrosne, Nicolas Pourel, et al.Pageof 17